Effects of Antiatherosclerosis in Carotid Artery by RNAi-Mediated Silencing of MCP-1 Expression

Annals of Vascular Surgery

Volumn 23, Issue 5, 2009, Pages 652-662

  Hu, Zuo jun ^a   Liao, Yi ^a   Hu, Ling yu ^a   Wang, Jia li ^a   Li, Jie ^a   Lu, Wei ming ^a   Wang, Shen ming ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE SILENCING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOWN-REGULATION; GENE THERAPY; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR SEQUENCE DATA; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 69749089225     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2009.01.002     Document Type: Article

References (35)

1. Touzé E. Natural history of asymptomatic carotid artery stenosis. Rev Neurol (Paris) 164 (2008) 793-800
2. Ross R., and Glomset J.A. The pathogenesis of atherosclerosis. N Engl J Med 295 (1976) 369-377
3. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
4. Glass C.K., and Witztum J.L. Atherosclerosis: the road ahead. Cell 104 (2001) 503-516
5. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-234
6. Greaves D.R., and Channon K.M. Inflammation and immune responses in atherosclerosis. Trends Immunol 23 (2002) 535-541
7. Shin W.S., Szuba A., and Rockson S.G. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 160 (2002) 91-102
8. Shyy Y.J., Li Y.S., and Kolattukudy P.E. Activation of MCP-1 gene expression is mediated through multiple signaling pathways. Biochem Biophys Res Commun 192 (1993) 693-699
9. Werle M., Schmal U., Hanna K., et al. MCP-1 induces activation of MAP-kinases ERK, JNK and p38 MAPK in human endothelial cells. Cardiovasc Res 56 (2002) 284-292
10. Yla-Herttula Lipten B.A., Rosenfeld M.E., et al. Expression of monocyte chemocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerosis lesions. Proc Natl Acad Sci USA 88 (1991) 5252-5256
11. Nelken N.A., Coughlin S.R., Gorden D., et al. Monocyte chemocyte chemoattractant protein 1 in human atheromatous plaques. Clin Invest 88 (1991) 1121-1127
12. Schwartz C.J., Valente A.J., Sprague E.A., et al. Atherosclerosis: potential targets for stabilization and regression. Circulation 86 Suppl. l (1992) III117-III123
13. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
14. Dawson T.C., Kuziel W.A., Osahar T.A., et al. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143 (1999) 205-211
15. Aiello R.J., Bourassa P.A., Lindsey S., et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 19 (1999) 1518-1525
16. Namiki M., Kawashima S., Yamashita T., et al. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler Thromb Vasc Biol 22 (2002) 115-120
17. Egashira K., Koyanagi M., Kitamoto S., et al. Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis. FASEB J 14 (2000) 1974-1978
18. Inoue S., Egashira K., Ni W., et al. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 106 (2002) 2700-2706
19. Ni W., Egashira K., Kitamoto S., et al. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation 103 (2001) 2096-2101
20. Coll B., Alonso-Villaverde C., and Joven J. Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker?. Clin Chim Acta 383 (2007) 21-29
21. Elbashir S.M., Harborth J., Lendeckel W., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
22. Tuschl T., Zamore P.D., Lehmann R., et al. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13 (1999) 3191-3197
23. Sullenger B.A., and Gilboa E. Emerging clinical application of RNA. Nature 418 (2002) 252-258
24. Yu J.Y., Deruiter S.L., and Turner D.L. RNA interference by expression of short interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 9 (2002) 6047-6052
25. Raman K.G., Barbato J.E., Ifedigbo E., et al. Inhaled carbon monoxide inhibits intimal hyperplasia and provides added benefit with nitric oxide. J Vasc Surg 44 (2006) 151-158
26. Chen Y.L., Chang Y.J., and Jiang M.J. Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits. Atherosclerosis 143 (1999) 115-123
27. Gordon A.A., Ferns A.L., Stewart L., et al. Arterial response to mechanical injury: balloon catheter deendothelialization. Atherosclerosis 3 (1992) 89-104
28. Yano T., Kawano H., Mochizuki H., et al. Atherosclerotic plaques composed of a large core of foam cells covered with thin fibrous caps in twice-injured carotid arterial specimens obtained from high cholesterol diet-fed rabbits. J Atheroscler Thromb 7 (2000) 83-90
29. Rolfe B.E., Stamatiou S., World C.J., et al. Leukaemia inhibitory factor retards the progression of atherosclerosis. Cardiovasc Res. 58 (2003) 222-230
30. Meltzer M.S., Stevenson M.M., and Leonard E.J. Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors. Cancer Res. 37 (1977) 721-725
31. Yoshimura T., Robinson E.A., Tanaka S., et al. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J Immunol 142 (1989) 1956-1962
32. Kuziel W.A., Morgan S.J., Dawson T.C., et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 94 (1997) 12053-12058
33. Viedt C., Vogel J., Athanasiou T., et al. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler Thromb Vasc Biol 22 (2002) 914-920
34. Nykanen A., Haley B., and Zamore P.D. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107 (2001) 309-321
35. Bernstein E., Caudy A.A., Hammond S.M., et al. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409 (2001) 295-296